7 Benefits of the Shingles Vaccine

7 Reasons to Get the Shingles Vaccine

7 Reasons to Get the Shingles Vaccine
Jacob Wackerhausen/iStock
While you may be familiar with shingles, the severity of its symptoms — a rash, fluid-filled blisters, nerve pain that can feel like burning or tingling — and the risk of serious long-term complications are often overlooked.

Shingles is a viral infection caused by the reactivation of the varicella-zoster (aka herpes zoster) virus, the same virus responsible for chickenpox. After you’ve had chickenpox, the virus can stay dormant in nerve tissue for decades before reactivating later in life.

Shingles can cause itchiness, fever, headache, and fatigue. It can sometimes lead to complications like long-term nerve pain, vision loss, and problems with hearing that linger long after the rash and blisters have cleared.

Vaccination is the most effective way to reduce your risk of developing shingles or its complications. Here’s a closer look at the benefits of getting the shingles vaccine.

1. It Significantly Lowers Your Risk of Getting Shingles

The key benefit of the shingles vaccine is its strong protection against infection, especially for people over 50.

Clinical trials have shown that the recombinant zoster vaccine (Shingrix) is about 97 percent effective in preventing shingles in 50- to 69-year-olds and about 91 percent effective in people age 70 and older with healthy immune systems.

“This vaccine is remarkable. Many vaccines don’t work as well in people age 65 and older as we would like. However, this vaccine does, even in people 70-plus or even 80-plus,” says William Schaffner, MD, a professor of infectious diseases at Vanderbilt University in Nashville, Tennessee, and a spokesperson for the Infectious Diseases Society of America.

The World Health Organization recommends the vaccine’s two-dose series for those age 50 and older, as well as younger adults who are immunocompromised because of disease or medication. That’s because the risk of shingles increases as the immune system naturally weakens with age.

2. It Provides Long-Lasting Protection, Up to a Decade and Perhaps Longer

Protection from the shingles vaccine holds up over time. Research shows that the vaccine remained over 80 percent effective after a decade.

“The studies are now going out beyond 10 years and showing there’s almost no diminution in protection. So far it’s 10 years and counting,” Dr. Schaffner says.

This longer-lasting protection sets it apart from vaccines like the seasonal influenza (flu) vaccine, which needs to be updated and given annually as immunity wanes and the virus changes, he says.

No boosters have been recommended for the shingles vaccine, but that may change as research on long-term efficacy continues.

3. Breakthrough Cases Are Milder and Shorter

It is possible to get shingles after getting vaccinated, but it is uncommon. And when shingles occurs after vaccination, symptoms are typically less severe than in those who didn’t get the vaccine, according to Jason Tetro, a microbiologist in Edmonton, Canada, and the author of The Germ Files and The Germ Code.

“If you do end up getting what is known as a breakthrough [infection] — in other words, your vaccine hasn't given you enough protection — you will have a milder case and you will have fewer complications,” Tetro says.

This matters because shingles isn’t like getting chickenpox. “It’s an eruption of this virus causing blisters over a segment of the body, often on the trunk. It creates a kind of stripe, a body of blisters on a red base. That’s why it’s called shingles — it looks like a shingle on a roof,” Schaffner says. “Anyone who's known someone with a moderately severe case of shingles doesn't want to get it.”

4. It Significantly Reduces the Risk of Chronic Nerve Pain

Postherpetic neuralgia (PHN) is one of the most serious complications of shingles, causing chronic nerve pain that can linger for months or years — potentially the rest of your life — after the initial shingles rash and other symptoms have resolved.

PHN can happen if nerve fibers get damaged by the shingles virus, leaving them hypersensitive to pain signals. Symptoms include itching; a burning, sharp, or stabbing pain in the nerves and skin; and extreme sensitivity to light touch on affected parts of the body.

“This is like an electrical nerve pain. And the usual pain medicine like ibuprofen or even something stronger like morphine may not resolve it or significantly reduce it,” says Ankush Bansal, MD, a lifestyle medicine physician and hospitalist in Westlake, Florida.

The severity of PHN can vary, but in significant cases it can become disabling. “That pain can be debilitating," he says. "And it can be something that lasts a long time, even lifelong, depending on the individual and how severe their shingles was and where it was.”

Because PHN can be difficult to treat once it develops, prevention through vaccination is valuable. Research suggests that the vaccine is about 91 percent effective in preventing PHN in people age 50 and older, and about 89 percent effective in those age 70 and older.

5. It Lowers the Risk of Serious Complications, Including Vision and Hearing Issues

Shingles complications can be serious, depending on where it develops in the body. When the virus affects certain nerve pathways, especially in the face, it can lead to complications that go beyond the skin.

“Just as the shingles can come out on the trunk, it can involve the face, and if it involves the eyes, it can actually scar the eyes and impair vision. And similar things have been recorded regarding deafness in the ear because the auditory nerve can be involved,” Schaffner says.

Keratitis, or inflammation of the cornea, usually develops within a month of getting shingles. It can lead to cornea numbness, scarring, and permanent eye damage, which can cause vision loss or blindness.

Ear pain, hearing loss, ringing in the ear (tinnitus), vertigo, and facial paralysis are also a risk if the virus affects facial nerves.

6. It May Help Protect Brain Health and Reduce Dementia Risk

Emerging research suggests a potential link between getting the shingles vaccine and a lower dementia risk.

After analyzing the health records of nearly 297,000 older adults, researchers for one study found that those who received the shingles vaccine were 20 percent less likely to develop dementia over the following seven years, compared with peers who didn’t get the vaccine.

A follow-up study suggested that the vaccine may even benefit those already diagnosed with dementia by slowing the progress of the disease.

“Different investigations in different locations by different investigators are all pointing in the same direction,” Schaffner says. “If you needed another reason to be vaccinated, I think that’s a pretty good reason.”

The mechanism behind the protection isn’t fully understood, though. “The question right now is why — that’s what we’re not totally sure of,” Dr. Bansal says. One of the leading explanations that researchers are exploring is inflammation, he says. When shingles reactivates, it can trigger inflammation affecting both the nervous system and blood vessels, but vaccination can lower this risk.

Consider it an evolving area of research, Bansal says. The Alzheimer’s Society in the United Kingdom is funding work exploring whether the shingles vaccine could be repurposed as a potential tool for dementia prevention or treatment.

7. It May Reduce the Risk of Heart Attack and Stroke

Promising research links the shingles vaccine to a lower risk of serious cardiovascular events like heart attack and stroke, Tetro says.

A study of more than a million people found that those who received the shingles vaccine had a 23 percent lower risk of cardiovascular health issues, including heart disease, heart failure, and stroke, compared with those who were unvaccinated. The research suggests that the effect lasts up to eight years after getting vaccinated.

A shingles infection can trigger inflammation, blood vessel damage, and clot formation, all of which are tied to heart disease, Tetro says. But by preventing these issues via vaccination, you’re more likely to keep heart health risks at bay.

The Takeaway

  • The shingles vaccine is recommended for people age 50 and older, as well as younger adults who are immunocompromised; it helps protect against shingles, a painful viral infection that can develop years after having chickenpox.
  • The vaccine is 97 percent effective in preventing the disease, with extended benefits that include decreasing the risk of serious complications like chronic nerve pain, vision loss, and hearing problems.
  • Research is also exploring how the vaccine may offer broader health benefits, including a potential link to lower risks of dementia and cardiovascular disease.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Shingles. MedlinePlus. April 20, 2024.
  2. Proven Outstanding Efficacy. Shingrix.
  3. Shingles (Herpes Zoster). World Health Organization. March 24, 2025.
  4. New Data Show Shingrix Can Provide at Least 10 Years of Protection Against Shingles in Adults Aged 50 Years and Over. GSK. October 19, 2022.
  5. Wu YT et al. From Consultation to Collaboration: A Patient-Centered Approach to Shingles Pain and Postherpetic Neuralgia Management. Journal of Personalized Medicine. May 8, 2025.
  6. Postherpetic Neuralgia. Mayo Clinic. February 10, 2023.
  7. Barshak M. Shingles of the Eye Can Cause Lasting Vision Impairment. Harvard Health Publishing. January 27, 2021.
  8. Ramsay Hunt Syndrome. Mayo Clinic. December 22, 2025.
  9. Eyting M et al. A Natural Experiment on the Effect of Herpes Zoster Vaccination on Dementia. Nature. April 2, 2025.
  10. Bai N. For Those Living With Dementia, New Study Suggests Shingles Vaccine Could Slow the Disease. Stanford Medicine. December 2, 2025.
  11. Taquet M et al. The Recombinant Shingles Vaccine Is Associated With Lower Risk of Dementia. Nature Medicine. July 25, 2024.
  12. Nair PA et al. Herpes Zoster. StatPearls. November 18, 2025.
  13. Early Treatment And Symptom Management For Shingles. Franciscan Health. January 27, 2025.
  14. Promising Research Into Shingles Vaccine as a Treatment for Alzheimer's Disease. Alzheimer’s Society. November 18, 2025.
  15. Shingles Vaccine Lowers the Risk of Heart Disease for Up to Eight Years. European Society of Cardiology. May 6, 2025.
Michelle-Seguin-bio

Michelle Seguin, MD

Medical Reviewer

Michelle Seguin, MD, is a board-certified family medicine, lifestyle medicine, and certified functional medicine physician (IFMCP). She is a practicing physician at Root Functional...

carmen-chai-bio

Carmen Chai

Author

Carmen Chai is a Canadian journalist and award-winning health reporter. Her interests include emerging medical research, exercise, nutrition, mental health, and maternal and pediat...